Verdezyne - About the company
Verdezyne is a deadpooled company based in Carlsbad (United States), founded in 2005. It operates as an Industrial biotechnology to produce chemicals from renewable non-food sources. Verdezyne has raised $81.6M in funding from investors like Monitor Ventures, Life Science Angels and Sime Darby. The company has 2087 active competitors, including 513 funded and 354 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Twist Bioscience.
Company Details
Verdezyne is a privately-held company that employs its biological expertise and proprietary computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. It is leveraging the power of biology to produce chemicals from renewable, non-food sources. Its proprietary technologies use fermentation followed by unique separations techniques. Their aim is to develop cost-effective alternatives to petrochemicals.
- Website
- verdezyne.com
- Social
- Email ID
- *****@verdezyne.com
Key Metrics
Founded Year
2005
Location
Carlsbad, United States
Stage
Deadpooled
Total Funding
$81.6M in 8 rounds
Latest Funding Round
Investors
Ranked
564th among 2087 active competitors
Similar Companies
Legal entities associated with Verdezyne
Verdezyne is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Verdezyne Inc CIN: 710982739 , United States, Active | - | 42 (As on Dec 31, 2011) | - |
Sign up to download Verdezyne's company profile
Verdezyne's funding and investors
Verdezyne has raised a total funding of $81.6M over 8 rounds. Its first funding round was on Feb 28, 2006. Its latest funding round was a Series C round on Nov 26, 2013 for $*****. 5 investors participated in its latest round. Verdezyne has 8 institutional investors.
Here is the list of recent funding rounds of Verdezyne:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 26, 2013 | 7641087 | Series C | 2494457 | 3704000 | 2816551 | 7716197 |
May 02, 2012 | 2719644 | Series B | 2505684 | 6771039 | 1872852 | 6258002 |
May 09, 2011 | 1605546 | Series B | 7213425 | 8340237 | 4768264 |
Access funding benchmarks and valuations. Sign up today!View details of Verdezyne's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Verdezyne's Competitors and alternates
Top competitors of Verdezyne include Ginkgo Bioworks, Syngenta and Twist Bioscience. Here is the list of Top 10 competitors of Verdezyne, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ginkgo Bioworks 2008, Boston (United States), Public | Autonomous labs for biotechnology, empowering scientists to design the living world | $796M | 81/100 | |
2nd |  Syngenta 2000, Basel (Switzerland), Acquired | Developer of technologies and sustainable farming practices for farmers | - | 75/100 | |
3rd |  Twist Bioscience 2013, San Francisco (United States), Public | Developer of a semiconductor-based DNA synthesis platform | $321M | 72/100 | |
4th | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
5th | Codexis 2002, Redwood City (United States), Public | Developer of high-performance enzymes for drug discovery | $111M | 68/100 | |
6th |  AskBio 2001, Durham (United States), Acquired | Developer of AAV technologies for treating genetic and complex disorders | $235M | 68/100 | |
7th | Amyris 2003, Emeryville (United States), Public | Developer of renewable products for industrial solutions | $487M | 68/100 | |
8th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
9th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
10th | _1530865304957.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 65/100 | |
564th | Verdezyne 2005, Carlsbad (United States), Deadpooled | Industrial biotechnology to produce chemicals from renewable non-food sources | $81.6M | 34/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Verdezyne's competitors? Click here to see the top ones
Verdezyne's Investments and acquisitions
Verdezyne has made no investments or acquisitions yet.
Reports related to Verdezyne
Here is the latest report on Verdezyne's sector:
News related to Verdezyne
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Verdezyne
Explore our recently published companies
- Autocal - Thane based, 2002 founded, Funding Raised company
- Indo Amines - Thane based, 1994 founded, Public company
- Taro International - Haifa based, 1992 founded, Unfunded company
- SmartCart AI - San Francisco based, Unfunded company
- 365 Retail Markets - London based, 2008 founded, Unfunded company
- Bishop Paiute Development Corporation - Bishop based, 2009 founded, Funding Raised company
